Mason & Associates (California)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mason & Associates (California)'s AMGN Position: Q2 2026 in Review
Mason & Associates (California) increased its Amgen (AMGN) stake by 4.5% in Q2 2026, buying an estimated $34.6K and bringing the position to 2,352 shares worth $852K. The position accounts for 0.14% of the portfolio, ranked #83.
Mason & Associates (California) first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mason & Associates (California) held 2,352 shares of Amgen worth $852K as of Q2 2026.
- Mason & Associates (California) bought 101 Amgen shares in Q2 2026, an estimated $34.6K.
- Amgen made up 0.14% of Mason & Associates (California)'s portfolio in Q2 2026, its #83 holding.
- Mason & Associates (California) first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mason & Associates (California)'s 13F filing for Q2 2026, filed 23 Jul 2026.